Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Align Technology Inc (NASDAQ:ALGN)

254.38
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
88.56
Today|||52-Week Range
258.88
+164.62%
Year-to-Date
Align Technology's Big Rally Is Starting to Slow
Nov 22 / TheStreet.com - Paid Partner Content
Wright Medical (WMGI) Rides on Strong Portfolio & Innovation
Nov 20 / Zacks.com - Paid Partner Content
AmerisourceBergen to Take Over H. D. Smith for $815 Million
Nov 22 / Zacks.com - Paid Partner Content
Intuitive Surgical Hits a 52-Week High on Solid Prospects
Nov 20 / Zacks.com - Paid Partner Content
Rising Costs Hurt Henry Schein, End-Market Trends a Tailwind
Nov 22 / Zacks.com - Paid Partner Content
Genomic Health Cancer Diagnostic Tests Grow Amid Cost Woes
Nov 17 / Zacks.com - Paid Partner Content
Medtronic Wins FDA Nod for Azure Pacemakers, Grows in CVG
Nov 21 / Zacks.com - Paid Partner Content
Medtronic Stock Dips on Preliminary Sales Drag, CRHF to Grow
Nov 17 / Zacks.com - Paid Partner Content
DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay
Nov 21 / Zacks.com - Paid Partner Content
Ecolab (ECL) to Refinance $375M Worth of Notes, Reduce Debt
Nov 17 / Zacks.com - Paid Partner Content
McKesson Gains From Distribution Business Amid Pricing Woes
Nov 21 / Zacks.com - Paid Partner Content
Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength
Nov 16 / Zacks.com - Paid Partner Content
Cramer: These 15 Stocks Are Must Haves For the End of Year
Nov 20 / TheStreet.com - Paid Partner Content
Intuitive Surgical (ISRG) to Gain From Procedural Business
Nov 16 / Zacks.com - Paid Partner Content
15 Must-Have Stocks: Cramer's 'Mad Money' Recap (Monday 11/20/17)
Nov 20 / TheStreet.com - Paid Partner Content
LabCorp Reports New Use of Agilent's Cancer Diagnostic Test
Nov 16 / Zacks.com - Paid Partner Content
Haemonetics (HAE) at 52-Week High: What's Driving the Stock?
Nov 20 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Myriad Genetics Right Now
Nov 16 / Zacks.com - Paid Partner Content
5 Stocks with Recent Price Strength to Boost Your Portfolio
Nov 20 / Zacks.com - Paid Partner Content
Illumina Introduces NextSeq 550Dx, Updates Use of MiSeqDx
Nov 16 / Zacks.com - Paid Partner Content
AmerisourceBergen's PharMEDium Slows Down, Competition Rife
Nov 20 / Zacks.com - Paid Partner Content
Myriad Genetics' Latest Alliance to Boost GeneSight Reach
Nov 15 / Zacks.com - Paid Partner Content
Varian's Halcyon Receives Shonin Approval, Grows in Oncology
Nov 20 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Grows on Strong Plasma, Competition Rife
Nov 15 / Zacks.com - Paid Partner Content
Align Technology-Glidewell Dental Deal to Boost iTero Uptake
Nov 20 / Zacks.com - Paid Partner Content
Here's Why Investors Should Buy Luminex (LMNX) Right Now
Nov 15 / Zacks.com - Paid Partner Content